Prime Health Cascara Sagrada 500 mg Capsules
Composition, doses, uses and warnings in Canada: Prime Health Cascara Sagrada 500 mg Capsules.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose microcristalline, Pullulane, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | Not specified | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
(Traditionally used in Herbal Medicine as a) stimulant laxative. (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner if symptoms persist.
- Contra-Indications
Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea. Do not use if you are pregnant or breastfeeding.
- Known Adverse Reactions
Hypersensitivity is known to occur, in which case, discontinue use.
Product record
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80032636
- Status
- Active licence
- Licence date
- 7 June 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80032636
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prime Health Cascara Sagrada 500 mg Capsules (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80032636-prime-health-cascara-sagrada-500-mg-capsules, updated 7 June 2012.